ETF Managers Group, LLC An2 Therapeutics, Inc. Transaction History
ETF Managers Group, LLC
- $2.78 Billion
- Q1 2023
A detailed history of ETF Managers Group, LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 6,742 shares of ANTX stock, worth $7,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,742Holding current value
$7,213% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ANTX
# of Institutions
40Shares Held
17.6MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$6.15 Million4.93% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.41 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.11 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny580KShares$620,3570.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY579KShares$619,3420.79% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $20.8M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...